When Amgen released its third-quarter financial results after the markets closed on Tuesday, the firm said that it had $3.66 in earnings per share (EPS) and $5.7 billion in revenue. That compared…
Chris Lange Amgen is set to report its most recent quarterly results after the closing bell on Tuesday. Wall Street expectations are muted.
Chris Lange 24/7 Wall St. has put together a preview of AT&T, Facebook, T-Mobile and the other most prominent earnings reports due this week.
The October 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Friday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Alphabet, Altria, Amazon.com, Boeing, Caterpillar, Chipotle Mexican Grill, E*Trade, Gap, Snap and Twitter.
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data has been compared with the previous report, and short interest in most…
The September 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Monday's top analyst upgrades, downgrades and initiations included Alcoa, Amgen, Apache, Chewy, Clorox, Concho Resources, Edwards Lifesciences, Occidental Petroleum and Walt Disney.
The August 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Amgen shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data is coming from the ongoing Phase 1 study evaluating AMG 510 in…
Chris Lange The top analyst upgrades, downgrades and initiations seen on Thursday included Amgen, Bank of America, Box, Chico's FAS, Microsoft, Netflix, NXP Semiconductors, StoneCo and Tiffany.
Many mergers have been announced or have closed, but just seven recent and pending deals have transformed how analysts and investors alike are having to view corporate America.
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
